홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → 2-[[1-Cyclohexyl-2-(2-phenyl-6-quinolyl)benzimidazole-5-carbonyl]amino]pentanedioic acid

HRID 1788421
인쇄

반응식

HRID 1788421 반응식
[CH:1]1([N:7]2[C:11]3[CH:12]=[CH:13][C:14]([C:16](O)=[O:17])=[CH:15][C:10]=3[N:9]=[C:8]2[C:19]2[CH:20]=[C:21]3[C:26](=[CH:27][CH:28]=2)[N:25]=[C:24]([C:29]2[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=2)[CH:23]=[CH:22]3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.ClC1C=CC(C2C(C3C=CC4C(=CC=C(C5N(C6CCCCC6)C6C=CC(C(NC(CC7C8C(=CC=C(O)C=8)NC=7)C(O)=O)=O)=CC=6N=5)C=4)N=3)=CC(C(N3CCCC3)=O)=CC=2)=CC=1.C[O:99][C:100](=[O:109])[C@H:101]([CH2:103][CH2:104][C:105]([O:107]C)=[O:106])[NH2:102].[OH-].[Na+]>>[CH:1]1([N:7]2[C:11]3[CH:12]=[CH:13][C:14]([C:16]([NH:102][CH:101]([CH2:103][CH2:104][C:105]([OH:107])=[O:106])[C:100]([OH:99])=[O:109])=[O:17])=[CH:15][C:10]=3[N:9]=[C:8]2[C:19]2[CH:20]=[C:21]3[C:26](=[CH:27][CH:28]=2)[N:25]=[C:24]([C:29]2[CH:30]=[CH:31][CH:32]=[CH:33][CH:34]=2)[CH:23]=[CH:22]3)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

5

반응물 4

HCID 14798Sodium HydroxideHCID 93032Dimethyl glutamateHCID 112130261-Cyclohexyl-2-(2-phenyl-quinolin-6-yl)-1H-benzoimidazole-5-carboxylic-acidHCID 576236852-[(2-{2-[4'-Chloro-4-(pyrrolidine-1-carbonyl)-biphen-2-yl]-quinolin-6-yl}-1-cyclohexyl-1H-benzoimidazole-5-carbonyl)-amino]-3-(5-hydroxy-1H-indol-3-yl)-propionic acid

생성물 1

HCID 5276162
2-[[1-Cyclohexyl-2-(2-phenyl-6-quinolyl)benzimidazole-5-carbonyl]amino]pentanedioic acid
수율 15%

실험 절차

Compound 237 was synthesized from Compound 201 as described for Compound 235, using L-glutamic acid dimethylester in place of L-5-hydroxytryptophane. In the 3rd step the protected intermediate was treated with aqueous sodium hydroxide for a 15% yield of the title compound

출처 및 근거

ORD 기록
ord-bfe9ed1a60e440c4aca3ac6e6d1cc065
출처 데이터셋
uspto-grants-2009_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07511145B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트